JPH0452280B2 - - Google Patents

Info

Publication number
JPH0452280B2
JPH0452280B2 JP59012156A JP1215684A JPH0452280B2 JP H0452280 B2 JPH0452280 B2 JP H0452280B2 JP 59012156 A JP59012156 A JP 59012156A JP 1215684 A JP1215684 A JP 1215684A JP H0452280 B2 JPH0452280 B2 JP H0452280B2
Authority
JP
Japan
Prior art keywords
formula
rebetskamycin
strain
nocardia
tetraacetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59012156A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59141597A (ja
Inventor
Edowaado Nitoruton Junia Donarudo
Aren Butsushu Jeemuzu
Tanburu Buradonaa Uiriamu
Uiriamu Doiru Terensu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPS59141597A publication Critical patent/JPS59141597A/ja
Publication of JPH0452280B2 publication Critical patent/JPH0452280B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP59012156A 1983-01-28 1984-01-27 レベツカマイシンとその製法 Granted JPS59141597A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/461,817 US4487925A (en) 1983-01-28 1983-01-28 Rebeccamycin and process for its preparation
US461817 1983-01-28

Publications (2)

Publication Number Publication Date
JPS59141597A JPS59141597A (ja) 1984-08-14
JPH0452280B2 true JPH0452280B2 (enFirst) 1992-08-21

Family

ID=23834041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59012156A Granted JPS59141597A (ja) 1983-01-28 1984-01-27 レベツカマイシンとその製法

Country Status (15)

Country Link
US (1) US4487925A (enFirst)
EP (1) EP0115350B1 (enFirst)
JP (1) JPS59141597A (enFirst)
KR (1) KR910002856B1 (enFirst)
AT (1) ATE36540T1 (enFirst)
AU (1) AU564256B2 (enFirst)
CA (1) CA1220149A (enFirst)
DE (1) DE3473459D1 (enFirst)
DK (1) DK160429C (enFirst)
ES (1) ES8607396A1 (enFirst)
FI (1) FI77264C (enFirst)
GR (1) GR81748B (enFirst)
IE (1) IE56651B1 (enFirst)
PT (1) PT78019B (enFirst)
ZA (1) ZA84582B (enFirst)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
CA2037596C (en) * 1990-03-06 1995-07-18 Kin Sing Lam Rebeccamycin analog by bromide precursor feeding
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
WO1993018766A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
EE200300456A (et) 2001-03-22 2004-02-16 Bristol-Myers Squibb Company Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
FR2956934B1 (fr) 2010-02-26 2012-09-28 Blink E Procede et dispositif d'emission/reception de signaux electromagnetiques recus/emis sur une ou plusieurs premieres bandes de frequences.
FR2990315B1 (fr) 2012-05-04 2014-06-13 Blink E Procede de transmission d'informations entre une unite emettrice et une unite receptrice

Also Published As

Publication number Publication date
FI840301A0 (fi) 1984-01-25
ES529170A0 (es) 1986-05-16
DK160429B (da) 1991-03-11
US4487925A (en) 1984-12-11
DK35684D0 (da) 1984-01-26
AU2372084A (en) 1984-08-02
IE56651B1 (en) 1991-10-23
FI840301L (fi) 1984-07-29
CA1220149A (en) 1987-04-07
DK160429C (da) 1991-08-19
KR840007257A (ko) 1984-12-06
FI77264C (fi) 1989-02-10
KR910002856B1 (ko) 1991-05-06
PT78019B (en) 1986-06-18
EP0115350B1 (en) 1988-08-17
IE840201L (en) 1984-07-28
ES8607396A1 (es) 1986-05-16
DE3473459D1 (en) 1988-09-22
ATE36540T1 (de) 1988-09-15
AU564256B2 (en) 1987-08-06
GR81748B (enFirst) 1984-12-12
JPS59141597A (ja) 1984-08-14
ZA84582B (en) 1984-09-26
PT78019A (en) 1984-02-01
DK35684A (da) 1984-07-29
EP0115350A3 (en) 1985-09-18
FI77264B (fi) 1988-10-31
EP0115350A2 (en) 1984-08-08

Similar Documents

Publication Publication Date Title
JPH0452280B2 (enFirst)
US4552842A (en) Process for producing rebeccamycin
EP0238011A2 (en) Polycyclic condensed amino sugar derivatives with anti-tumor and anti-bacterial activity, produced by streptomyces
EP0271581A1 (en) Novel compounds dc-88a and dc-89a1 and process for their preparation
EP0368349A2 (en) Serine analogs of BU-3608 antibiotics
EP0388956B1 (en) Phthalinide derivative, pharmaceutical composition and use
FR2555586A1 (fr) Complexe antibiotique bbm-2478
JPH0216756B2 (enFirst)
JP2863637B2 (ja) 新規なアミノオリゴ糖誘導体およびその製造方法
FR2568892A1 (fr) Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine
CZ281476B6 (cs) Polyhydroxycyklopentanové deriváty, způsob výroby a produkční mikroorganismy
JP2833181B2 (ja) Ｆｒ９０１３７５物質およびその製造法
CN1109687C (zh) 具有抗肿瘤活性的大环内酯类及其制备方法和用途
JPWO1988000591A1 (ja) 新規物質ｄｃ―９２ｂ及びｄｃ―９２ｄ
EP0139458A2 (en) An antibiotic compound and its production
JPH03141290A (ja) 抗腫瘍抗生物質ｂｍｙ―４１３３９
JP3759207B2 (ja) 抗菌剤及び医薬組成物
JP3124373B2 (ja) 免疫抑制物質
EP0491281B1 (en) A 4-hydroxypyridine derivative, method for preparing the same, and a pharmaceutical composition comprising the same
JP2821756B2 (ja) Ｂｕ―３８６２ｔ抗腫瘍性抗生物質
CA1321788C (en) Antitumor substance, process for preparing the same and anticancer agent containing the same
JP2971204B2 (ja) 新規物質ｗｋ−２９５５およびその製造法
JPH0367077B2 (enFirst)
KR0130473B1 (ko) 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도
KR0177585B1 (ko) 항종양성 물질 b e-13793c-생성 균주